ResearcherKeio UniversityNo recent work listed

Fumihiro Kikuyama

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2513-5641; OpenAlex author ID A5034489303. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2023: 1 paper

Papers 1

Ingenol mebutate inhibits the growth of pancreatic cancer cells in vitro via STING with an efficacy comparable to that of clinically used anticancer agents. Co-author DOI 10.1007/s11418-023-01682-1 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Susumu Kitanaka · 1 shared paper, 2023 · strength 0.20
- Paper Ingenol mebutate inhibits the growth of pancreatic cancer cells in vitro via STING with an efficacy comparable to that … DOI 10.1007/s11418-023-01682-1 ↗
Tomonori Nakamura · 1 shared paper, 2023 · strength 0.20
- Paper Ingenol mebutate inhibits the growth of pancreatic cancer cells in vitro via STING with an efficacy comparable to that … DOI 10.1007/s11418-023-01682-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.